Alex Tagliani, also known by his racing name TAG, developed a passion for racing at the age of 10 when he was introduced to karting on a visit to see his grandfather in Northern Italy. Currently competing in the Nascar Canadian Tire Series driving the Tagliani Autosport Epipen #18 car, the Montreal native has shown his fans that he can drive anything. Whether it be IndyCar, Nascar, a Prototype or a sedan, Alex's talent and experience is second to none in Canada. In addition during 2016 Alex will race four endurance races in the European "Blancpain GT Series” competing in a Mercedes AMG. A fierce competitor on-track, Alex has many passions including his training and nutrition and his newly formed charitable foundation, the Tagliani Foundation. Alex always takes precautions when managing his life-threatening allergies to peanuts and tree nuts, which includes carrying his EpiPen® and states that living with food allergies is not something that holds him back in life, he's always ready for a challenge! For more information visit www.tagliani.com.


Food Allergy Canada (formerly Anaphylaxis Canada) is a national non-profit charitable organization committed to educate, support, and advocate for the needs of individuals and families living with food allergy and the risk of anaphylaxis, as well as to support and participate in research related to food allergy and anaphylaxis. With offices in Toronto, Ontario and Kamloops, British Columbia, we provide information, programs and services, resources and support to communities across the country. For more information, visit www.foodallergycanada.ca.


EpiPen® and EpiPen® Jr (epinephrine) Auto-Injectors are indicated for the emergency treatment of anaphylactic reactions in patients who are determined to be at increased risk for anaphylaxis, including individuals with a history of anaphylactic reactions. Selection of the appropriate dosage strength is determined according to patient body weight. EpiPen® and EpiPen® Jr Auto-Injectors are designed as emergency supportive therapy only. They are not a replacement for subsequent medical or hospital care. After administration, patients should seek medical attention immediately or go to the emergency room. For the next 48 hours, patients must stay within close proximity to a healthcare facility or where they can call 911. To ensure this product is right for you, always read and follow the label. Please consult the Consumer Information leaflet in your product package for complete dosage and administration instructions. For other details on EpiPen® or educational and product safety information, please visit www.EpiPen.ca.